findmyKOL

Michael Sjoding, MD

Enriched profile

Associate Professor, Division of Pulmonary and Critical Care Medicine, University of Michigan; Associate Director for Research Implementation, AI & Digital Health Initiative · University of Michigan

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Ann Arbor, MI · Midwest · United StatesSpecialtyPulmonary DiseaseFocusRespiratory Support and Mechanisms+4
Active KOLfindmyKOL type: EliteLatest publication2025Online presenceverified 2026Payments2021–2021NIH funding2017–2026

Michael Sjoding is Associate Professor, Division of Pulmonary and Critical Care Medicine, University of Michigan; Associate Director for Research Implementation, AI & Digital Health Initiative at University of Michigan. OpenAlex indexes 205 publications with 4,937 citations (h-index 40); ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 11 Oct 2026

Overview

Updated 16 Oct 2026

Michael Sjoding, MD, is Associate Professor, Division of Pulmonary and Critical Care Medicine, University of Michigan. The public record shows 205 publications with 4,937 citations (h-index 40), centered on Respiratory Support and Mechanisms, Sepsis Diagnosis and Treatment, Machine Learning in Healthcare. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 1 companies, 4 NIH-funded awards (2017–2026).

  • Most recent indexed publication: 2025 · JMIR medical informatics
  • Top research focus: Respiratory Support and Mechanisms
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 1 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Respiratory Insufficiency1 trialSepsis / Serious Bacterial

Research focus

OpenAlex concept fingerprint
Respiratory Support and MechanismsSepsis Diagnosis and TreatmentMachine Learning in HealthcareNeonatal Respiratory Health ResearchNosocomial Infections in ICU

Drugs & molecules

across trials, industry payments and publications
Tyvasogeneric · TreprostinilClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
United Therapeutics CorporationClinical trials—Industry payments1University of MichiganClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
205publications

Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.

4,937citations

Total citations across indexed works.

40h-index

Hirsch index (OpenAlex). i10-index 88.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
1companies · 2021–2021

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
4NIH grants · 2017–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

1 company reported payments to CMS in program years 2021–2021. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    53.2%
    Corticosteroid36.4%
    Trelegy Ellipta30%Symbicort21%Breztri Aerosphere15%Budesonide-Formoterol Fumarate15%Qvar Redihaler11%Dulera9%
    Part D<11 patients
    beta2-Adrenergic Agonist13.2%
    Albuterol Sulfate Hfa79%Ventolin Hfa21%
    Part D<11 patients

    + 1 more class in this area

  • Anti-infectives

    17%
    Macrolide Antimicrobial14.7%
    Azithromycin100%
    Part D≥27 patients
    Short-acting sulfonamides2.3%
    Sulfamethoxazole-Trimethoprim100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    14.9%
    Corticosteroid14.9%
    Prednisone100%
    Part D≥26 patients
All 5 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

4 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Theodore John Iwashyna41Robert P. Dickson41Thomas S. Valley29Hallie C. Prescott28Jenna Wiens28Colin R. Cooke21Rishi Chanderraj21Anna Barker15Andrew J. Admon14Kevin R. Ward14Dru D. Claar13Ivan Nathaniel Co13Sardar Ansari12Jakob Israel McSparron12Nicole R. Falkowski11Mark Nuppnau11Sarah Jabbour11Shengpu Tang8Kathleen A. Stringer8David F. Fouhey8Michelle Ng Gong8Ella Annabelle Kazerooni8Meeta Prasad Kerlin8Rachel K. Hechtman7Scott W. Ketcham7Brahmajee K. Nallamothu7Kayvan Najarian7Christopher E. Gillies7Jennifer N. Ervin7Michael R. Mathis6Narathip Reamaroon6Njira Lucia Lugogo6Gary E. Weissman6Jennifer M. Baker6Pauline K. Park6Ryan P. Barbaro6Robert J. Woods6Christopher A. Brown6Ruchi Sharma6Karandeep Singh5

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/michael-sjoding-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/michael-sjoding-71645514a

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • X / Twitter

    x.com/msjoding

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances
  • ATS Breathe Easy podcast: Critical Perspective

    physician agreement and disagreement about the diagnosis of ARDS with Dr. Michael Sjoding

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thoracic.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.